Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC.
Lupo F, Pezzini F, Pasini D, Fiorini E, Adamo A, Veghini L, Bevere M, Frusteri C, Delfino P, D'agosto S, Andreani S, Piro G, Malinova A, Wang T, De Sanctis F, Lawlor RT, Hwang CI, Carbone C, Amelio I, Bailey P, Bronte V, Tuveson D, Scarpa A, Ugel S, Corbo V. Lupo F, et al. Among authors: ugel s. Gut. 2024 Apr 26:gutjnl-2023-329807. doi: 10.1136/gutjnl-2023-329807. Online ahead of print. Gut. 2024. PMID: 38670629 Free article.
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.
Mazzocco M, Martini M, Rosato A, Stefani E, Matucci A, Dalla Santa S, De Sanctis F, Ugel S, Sandri S, Ferrarini G, Cestari T, Ferrari S, Zanovello P, Bronte V, Sartoris S. Mazzocco M, et al. Among authors: ugel s. Immunology. 2015 Sep;146(1):33-49. doi: 10.1111/imm.12477. Epub 2015 Jun 15. Immunology. 2015. PMID: 25959091 Free PMC article.
MDSCs in cancer: Conceiving new prognostic and therapeutic targets.
De Sanctis F, Solito S, Ugel S, Molon B, Bronte V, Marigo I. De Sanctis F, et al. Among authors: ugel s. Biochim Biophys Acta. 2016 Jan;1865(1):35-48. doi: 10.1016/j.bbcan.2015.08.001. Epub 2015 Aug 6. Biochim Biophys Acta. 2016. PMID: 26255541 Review.
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
Sandri S, Bobisse S, Moxley K, Lamolinara A, De Sanctis F, Boschi F, Sbarbati A, Fracasso G, Ferrarini G, Hendriks RW, Cavallini C, Scupoli MT, Sartoris S, Iezzi M, Nishimura MI, Bronte V, Ugel S. Sandri S, et al. Among authors: ugel s. Cancer Res. 2016 May 1;76(9):2540-51. doi: 10.1158/0008-5472.CAN-15-2318. Cancer Res. 2016. PMID: 27197263
Tumor-Induced Myeloid-Derived Suppressor Cells.
De Sanctis F, Bronte V, Ugel S. De Sanctis F, et al. Among authors: ugel s. Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.MCHD-0016-2015. Microbiol Spectr. 2016. PMID: 27337449 Free article. Review.
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53.
Malpeli G, Barbi S, Zupo S, Tosadori G, Scardoni G, Bertolaso A, Sartoris S, Ugel S, Vicentini C, Fassan M, Adamo A, Krampera M, Scupoli MT, Croce CM, Scarpa A. Malpeli G, et al. Among authors: ugel s. Oncotarget. 2017 Feb 14;8(7):11809-11826. doi: 10.18632/oncotarget.14683. Oncotarget. 2017. PMID: 28107180 Free PMC article.
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.
Sandri S, De Sanctis F, Lamolinara A, Boschi F, Poffe O, Trovato R, Fiore A, Sartori S, Sbarbati A, Bondanza A, Cesaro S, Krampera M, Scupoli MT, Nishimura MI, Iezzi M, Sartoris S, Bronte V, Ugel S. Sandri S, et al. Among authors: ugel s. Oncotarget. 2017 May 23;8(50):86987-87001. doi: 10.18632/oncotarget.18115. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152058 Free PMC article.
81 results